Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/NVO

NVO

Novo Nordisk A/S

Healthcare - DK - listed in USD

Novo Nordisk A/S, a leading global healthcare company founded in 1923 and headquartered in Bagsværd, Denmark, develops, manufactures and markets pharmaceutical products and services focused on diabetes care, obesity management, rare blood d…

HQ: Bagsvaerd, CR, Denmarkwww.novonordisk.com

USD43.07-2.14%vs prev. close

Market snapshot

Price

USD43.07

Daily move

-2.14%

P/E

10.8

EPS TTM

4.00

Dividend yield

4.08%

Beta

0.34

Market cap

144.0B

Price history

NVO price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Novo Nordisk	NVO	Drug Manufacturers - General	144.0	10.8	4.08%	-7.6%	-7.2%	-1.9%	+13.5%	-20.7%	-15.3%

Subscribe to Equity Analytics to compare NVO with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.